Examination of Herbal-drug Interactions: Implications for Patient Safety and Healthcare Practice in Lebanon: A Cross-sectional Study

All published articles of this journal are available on ScienceDirect.

RESEARCH ARTICLE

Examination of Herbal-drug Interactions: Implications for Patient Safety and Healthcare Practice in Lebanon: A Cross-sectional Study

The Open Public Health Journal 07 Nov 2024 RESEARCH ARTICLE DOI: 10.2174/0118749445336623241009061157

Abstract

Background

The lack of regulation of herbal products in Lebanon, and potential risks associated with herbal-drug interactions potentiates the need for increasing awareness and understanding of herbal-drug interactions among patients and athletes in Lebanon. This study highlights the need for increased awareness and understanding of herbal-drug interactions among healthcare professionals and patients in Lebanon.

Objective

The study aims to investigate the level of knowledge and understanding of herbal interactions and conventional medications among Lebanese patients. Moreover, the study will examine the Lebanese patients’ awareness, perception towards Herbal Drug Interactions (HDIs) and the role of pharmacists in patient education and information provided about herbal medicine.

Methods

A cross-sectional, descriptive study was performed from March to May 2023 consisting of Lebanese outpatients (General Population and Athletes) aged 20 years and older at Lebanese community pharmacies who agreed to respond to the survey questionnaire from medications, sociodemographic and clinical characteristics were collected from patients via face-to-face Interviews, and a well-structured survey questionnaire administered to a representative sample of Lebanese patients to gather data via Online Google Platform Surveys. All these calculations are performed using Statistical Package for the Social Sciences Software (SAS), SAS Institute. Descriptive statistics are used to describe independent variables. One-Way ANOVA analysis followed by a t-test (binary logistic regression) was performed to identify factors associated with HDI(s).

Results

The results of this study provide valuable insights into the current state of awareness and highlight areas for improving patient education regarding herbal-drug interactions, which included 501 patients, with a mean age of 50.248 years, 53.1% of them being female 58.9% and males 41.1%. The category of Lebanese patients who consumed Herbal medications during the last 12 months accounted for 46.7% and advising others to take herbal medication, 47.9%, versus patients who don’t consume herbal medications 53.3%. Lebanese patients get their recommendation for herbal medication use from mass media such as TV, ads, social media (32.3%), pharmacist (21.6%), family members with friends and neighbours (19%), personal reading/ Internet search (13.6%), didn’t get any recommendation (10.8%), Herbalist (9.8%), and Physician (7.4%).

Conclusion

The study provides valuable insights into the awareness of herbal-drug interactions and the need for understanding these interactions among professionals and patients where various factors affect negatively the unauthorized use of herbal products such as the economic crisis in Lebanon which negatively affected the purchasing power of Lebanese patients to buy their conventional medications, the affordable prices of herbal medications, and the reputation of folk medicine practiced by ancestors.

Keywords: Herbal products, Complementary and alternative medicine (CAM), Pharmacists, Lebanese patients - herbal rug Interactions (HDI), Health belief model, Patient safety.

1. INTRODUCTION

Herbal medicine is considered the oldest type of therapy for preventing or treating diseases [1]. Medicine history was initiated from herbal medicine itself, and this initial study and knowledge bloomed from the Middle East and Europe [2]. Nowadays, this type of medicine is known as complementary and alternative medicine (CAM) in most countries [3]. Recently, the use of CAM has increased worldwide in the past decade. Herbal medicine presents a crucial healthcare methodology in various traditional cultures [4], where the use of herbal medicine maybe the only form of medicine that is available for such a population [5]. Recently, the World Health Organization estimated that 80% of people worldwide rely on herbal medicines as part of their primary health care [6]. Despite the high prevalence of public use of herbs, still, fewer than half of patients who use CAM typically discuss it with their clinician or even seek a pharmacist’s advice [7, 8].

Many reasons have led to the tremendous use of herbal medicine among Lebanese patients [8]. It has vast availability in the market as an over-the-counter product, it is cost-effective and is safe and effective. Excessive consumption of herbal medicine was also reported in Gulf countries, where 74% of respondents in Saudi Arabia sought a herbalist, spiritual healers, or honeybee providers for medical reasons [9]. Kuwaiti population in similar studies has shown a very high prevalence of natural herbal medicine use, even without a doctor’s consultation [10]. Patients are usually convinced that herbal products are safer than synthetic products “if herbs are not effective, at least they are non-toxic” [11, 12]. Still, this is not 100% guaranteed, where herbal products are not regulated by quality control validations [13], and the dispensed active ingredient is not pure in case the extraction of the raw plant is not efficient or complete [12]. In addition to this issue, the Lebanese market lacks the regulatory process of herbal medicine distribution, where many products may contain additives, excipients, and contaminants that are not labelled on the product [14].

Previously, many articles have assessed the inter- actions between herbal medicine and conventional drugs [1]. These articles have revealed that concurrent use of herbal products with conventional medications can lead to interactions that may affect drug efficacy and safety [15]. The word Herb-drug interaction (HDI) was found in the year 2000, which includes examples such as bleeding occurring due to combining Gingko with warfarin or cardiac arrhythmia upon mixing digoxin with St. John’s wort and so many other unlimited fatal sequala [16]. The Phyto vigilance of drug-plant interactions is complicated due to numerous factors like the patient’s comorbid conditions, pharmacogenomic variations, and poly- pharmacy [11]. On the other hand, Phyto vigilance studies have elaborated on several causes of drug-plant interactions, such as multiple botanical constituents, mis- identification of therapeutic dose, mislabelling, and contamination [17, 18]. Thus, information regarding herb–drug interactions is potentially problematic, especially in critical cases such as cardiovascular illness, breast cancer and patients with kidney diseases [19-21]. Yet, as we move toward integrating patient-centered treatment, a detailed understanding of herb-drug interactions is required to optimize the benefits of favorable interactions while avoiding the dangers of potentially dangerous combination [22].

Although many studies have indicated a high degree of interest in alternative medicine among the public worldwide, the level of herbal knowledge and skills concerning the interactions is not adequately discovered in patients and pharmacists. The pharmacist’s role in providing the proper counselling and educating the patient about the appropriate administration, dosing, and specific herbal drug requirements was not stated before. The objective of this study was to determine the Lebanese patients’ awareness, perception towards HDIs and the role of pharmacists in giving full consultation and information on herbal medicine use. This study addresses the potential risks associated with the concurrent use of herbal medicines and conventional drugs, and it emphasizes the need for effective strategies and a comprehensive database to predict and understand herb-drug interactions.

2. METHODS

The study protocol was approved by the Institutional Review Board of the Lebanese International University (2023RC-006-LIUSOP). The collection and processing of the data in this study complied with data protection and privacy. This cross-sectional descriptive study was performed from March until May 2023.

Participants who accepted to fill the questionnaire were interviewed during their visit to a community pharmacy. Patients who are eligible to fill the questionnaire should be older than 20 years of age. Each participant should report any medical condition and must specify the conventional medications they are taking. This latter section was demonstrated to assess the participants’ knowledge about herbal medicine, the practice they adopt, especially with respect to their conventional therapies, and their attitudes towards safety, efficacy, and herbal products' effectiveness in treating diseases and relieving clinical symptoms.

The questionnaire included several sections: socio- demographic status, past medical history, past medication history, and herbal products section. The first carried the details about the patient’s gender, age, height and weight, nationality, area of residence, educational level, work status, marital status, monthly income, and the availability of health insurance contracts. In the past medical history, the questions were asked to collect data about the surgical history, comorbidities, reason for clinical visits or physician’s call, numbers of clinical visits over a year, lab evaluation’s documents in the last 12 months, and the medications prescribed by the physician or even taken as over the counter remedies. The herbal products section has included all the details about patient’s knowledge and competence towards herbal products benefits, adverse effects, risks of toxicity, herbal-drug interactions, and disease-herbs interactions. It also included the patient’s perspectives and attitude towards herbal products, their use, the purpose for the use, their proper administration, their accurate dose measurement, the need for spacing between herbal products and conventional therapy, along with any specific considerations. By the end of the questionnaire, the participants were asked if the prescriber or the pharmacist had educated them about the use, the benefits, and the expected onset of action or the expected side effects.

The statistical analysis and the calculations were performed using Statistical Package for the Social Sciences Software (SPSS), SAS Institute. Descriptive statistics used to describe independent variables. One-Way ANOVA analysis followed by t-test (binary logistic regression) was performed to identify factors associated with HDI(s). Estimating the Lebanese Population size in 2023 is around 5,353,930 [23], with the power to provide a 95% confidence interval [24]. So, for all the previous clues, it has been shown that the recommended minimal sample size we should consider is 384. Categorical variables were reported using numbers and percentages, whereas continuous variables were presented using means (M) and standard deviations (SD). The association of HIDs with each Lebanese patient’s demographic and clinical characteristics was tested using Tukey’s range test to find means that are significantly different from each other, Pearson’s test for categorical variables, One-Way ANOVA analysis followed by T-test for continuous variables. All variables in the bivariate analysis with a p-value <0.05 were included in the logistic regression model unless they were strongly correlated. Therefore, the binary logistic regression allowed the assessment of relationships between binary dependent variable (consuming herbal medications use/not consuming herbal medications), the usage patterns of different types of herbal products or supplements and the current usage of conventional treatment. Thus, it was possible to identify the significant contributing factors to HDIs.

Table 1.
Distribution of lebanese patients according to socio-demographic characteristics.
Characteristic Frequency (%)
Ages -
20-30 183 (36.5%)
30-40 80 (15.9%)
40-50 76 (15.1%)
+50 96 (19.1%)
Sex -
Male 206 (41.1%)
Female 295 (58.9%)
Nationality -
Lebanese 444 (88.6%)
Non-Lebanese 57 (11.4%)
Area of residence -
Bekaa 61 (12.2%)
Mount Lebanon 133 (26.5%)
Beirut 178 (35.5%)
South 76 (15.2%)
North 53 (10.6%)
Type of residence -
Urban 363 (72.5%)
Rural 138 (27.5%)
Educational level -
Primary Education 23 (4.6%)
High School 57 (11.4%)
University 421 (84%)
Work Status -
Healthcare provider 180 (35.9%)
Non-healthcare provider 321 (64.1%)
Marital status -
Single 285 (56.9%)
Married 166 (33.1%)
Divorced 41 (8.2%)
Widowed 9 (1.8%)
Monthly income -
Less than $ 100 171 (34.1%)
$100-$500 199 (39.7%)
$600-$1000 87 (17.3%)
More than $1000 44 (8.8%)
Health insurance -
NSSF 134 (26.7%)
COOP 48 (9.6%)
Private 150 (29.9%)
Army 28 (5.6%)
None 132 (26.3%)
Smoking status -
Yes, current smoker 280 (55.9%)
Yes, previous smoker 41 (8.2%)
No, not a smoker 180 (35.9%)
Alcohol consumption -
Yes, current alcohol consumer 114 (22.8%)
Yes, Previous alcohol consumer 34 (6.8%)
No, I don't consume alcohol 353 (70.5%)
Lifestyle -
Healthy and Active 192 (38.3%)
Sedentary 309 (61.7%)
Do you have difficulty in sleeping? -
Yes 274 (54.7%)
No 227 (45.3%)
Are you athletic? -
Yes 210 (41.9%)
No 291 (58.1%)
Do you have Frequent visits to Physicians? -
When needed 323 (64.5%)
Periodically 62 (12.4%)
Never 323 (64.5%)
Do you have Frequent visits to pharmacies? -
When needed 346 (69.1%)
Periodically 60 (12%)
Never 95 (19%)
How many times you do lab tests? -
When needed 323 (64.5%)
Periodically 94 (18.8%)
Never 84 (16.8%)
Have you ever been tested for herbal substance in your blood tests? -
Yes 106 (21.2%)
No 395 (78.8%)

3. RESULTS

The questionnaire was filled by 501 Lebanese participants and was distributed over 5 governates of Lebanon (Beirut, Mount Lebanon, South, North, and Beqaa). Most of the participants were females 58.9%, 45.9% of participants aged between 20 and 30 years of age, 55.9% were smokers and 70.5% were non-alcoholic consumers. 35.5% of participants live in the Capital of Beirut, Lebanon, and 61.7% of participants reported a sedentary lifestyle and 54.7% had difficulty in sleeping. Other subjective data were included in the sociodemographic domain, such as monthly income and marital status (Table 1).

3.1. Herbal Usage and Herbal- Drug Interactions (HDIs) related Knowledge

46.7% of the population documented that they consumed herbal medications during the last 12 months. These medications were used as supplements, remedies and prophylaxis. 33% individuals used herbal medications as cold remedies, 30% used other herbal products for gastrointestinal disorders such as abdominal cramps, flatulence, and nausea, 20% of respondents used herbal products to boost energy or to improve sexual desire and libido. Some medications were prescribed during a physician’s visit, while other drugs were recommended as OTC products for self-treatable illnesses such as constipation and diarrhea. Whereas, 27% of participants have consumed herbal products for constipation and 29% have taken herbal products to treat diarrhea. In this study, we have categorized the answers of the patients between consumers of herbal products available in community pharmacies with precise doses and labelled instructions from patients who consider herbal products can be consumed from natural food products found in Lebanese kitchens such as flavourings and spices (Table 2).

While questioning the participants about the source of information regarding the use of herbal supplements or herbal products used in food, 32.3% of them considered that social media (TV, Instagram, Facebook, and reels) is the best resource of information, and only 7.4% participants take herbal medicine or natural flavourings if recommended by the physician. Herbal products used in preparing food were plenty. The participants documented the use of variable types of flavourings and seasonings such as thyme (Thymus vulgaris, 34.53%), garlic (Allium sativum, 33.93%), cinnamon (Cinnamomum verum, 30.73%), Apple Cider Vinegar (Acetic acid, 30.73%), Curcumin or Turmeric (Curcuma longa, 24.95%), Romarin or Rosemary (Salvia Rosmarinus, 23.95%), while herbal medications as oral pills used by them were Ginkgo biloba (26.94%), Panax Ginseng (Panax quinquefolius L, 24.15%), Garcinia cambogia (Garcinia gummi-gutta, 22.15%), Valeriana (Valeriana officinalis, 21.55%), Echinacea (Echinacea purpurea, 21.35%), and Ashwagandha (Withania somnifera, 21.15%) (Figs. 1-4).

Table 2.
Herbal product use purposes by lebanese patients as a supplement medication or in food.
Uses of Herbal Products by Lebanese Patients Yes, I use it as a herbal supplement medication
N (%)
Yes, I use it in food
N (%)
No, I don’t use it
N (%)
Treatment of dermatologic conditions 133 (26.54%) 92 (18.36%) 276 (55.08%)
Treatment of hypertension 104 (20.75%) 91 (18.16%) 306 (61.07%)
Treatment of diabetes 77 (15.36%) 127 (25.34%) 297 (59.28%)
Treatment of kidney diseases 119 (23.75%) 84 (16.76%) 298 (59.48%)
Treatment of gynecological diseases or sexual problems 109 (21.75%) 107 (21.35%) 285 (56.88%)
Treatment of gastric problems 154 (30.73%) 128 (25.54%) 219 (43.71%)
Supportive for weight gain 108 (21.55%) 111 (22.15%) 282 (56.28%)
Supportive for weight loss 123 (24.55%) 130 (25.94%) 248 (49.50%)
Supportive as aphrodisiac 100 (19.96%) 104 (20.75%) 297 (59.28%)
Supportive for constipation relief issues 141(28.14%) 132 (26.34%) 228 (45.50%)
Supportive for diarrhea relief issues 129 (25.74%) 145 (28.94%) 227 (45.30%)
Supportive for relieving or killing pain 141 (28.14%) 130 (25.94%) 230 (45.90%)
Protection from common cold/flu 165 (32.93%) 134 (26.74%) 202 (40.31%)
Protection from alopecia or dandruff 136 (27.14%) 116 (23.15%) 249 (49.70%)
Protection from infections 134 (26.74%) 121 (24.15%) 246 (49.10%)
Protection from dyslipidemia and cardiovascular disease 129 (25.74%) 100 (19.96%) 272 (54.29%)
Protection from osteoporosis 125 (24.95%) 105 (20.95%) 271 (54.09%)
Relaxation from insomnia 137 (27.34%) 124 (24.75%) 240 (47.90%)
Relaxation from depression 137 (27.34%) 107 (21.35%) 257 (51.29%)
Relaxation from muscle spasms 142 (28.34%) 109 (21.75%) 250 (49.90%)
Energy booster: increase energy and endurance 145 (28.94%) 114 (22.75%) 242 (48.30%)
Energy booster: improving athletic performance 129 (25.74%) 114 (22.75%) 258 (51.49%)
Energy booster: not being detected in blood tests 120 (23.95%) 116 (23.15%) 265 (52.89%)
Fig. (1).

Distribution of Lebanese patients according to their conventional medical treatment

Fig. (2).

Adverse events after consuming herbal medications by Lebanese patients during the last 12 months.

Furthermore, 54.3% of Lebanese patients did not experience any of adverse events or side effects when consuming herbal plants or medication alone, while 2.4% admit that they experienced adverse events when consuming herbal plants or medication alone. On the other hand, 1.8% experienced adverse events when consuming it with their conventional medication.

Finally, 38.52% of Lebanese patients agree that natural and herbal medicine have side effects, 35.12% of Lebanese patients neither agree nor disagree that natural medicine is more effective than conventional therapy, while 33.93% agree that natural medicine is more effective than conventional therapy, as illustrated in Fig. (2).

In addition, 46.10% of Lebanese patients agree that herbal medicines are beneficial in healthcare management, and 40.71% of Lebanese patients agree that herbal supplements should be used as a substitute for medications after proper sports training, nutrition, and recovery practices. 37.32% of Lebanese patients agree, while 30.73% neither agree nor disagree that herbal supplements can interact with other medications and supplements that you may be taking, 44.51% of Lebanese patients agree that there is scientific research that supports the use of herbal supplements. 37.52% of Lebanese patients agree and 35.92% neither agree nor disagree that there are potential long-term health effects of taking herbal supplements, with 32.93% agreeing that the use of herbal supplements or herbal plants should be limited only to patients who have failed conventional therapy.

Furthermore, 32.93% agree that herbal medicine is safer than conventional medicine, 39.32% of Lebanese patients agree that they are aware of the potential risks and side effects associated with herbal supplements or plants they used, 36.72% of Lebanese patients agree that they know which exact daily amount or dose of herbal plant or herbal supplement they should take for their condition, 40.51% of Lebanese patients agree that when taking any conventional medication along with herbal supplement, the herbal supplement and conventional medication may interact together, 41.91% of Lebanese patients agree that herbal supplements should be regulated and controlled by the Ministry of Health and regulatory bodies to ensure safety and efficacy, 40.71% of Lebanese patients agree that there is a need for education about the risks and benefits of herbal addressed to the general population, 41.51% of Lebanese patients agree that herbal supplements got a health protective effect, 43.71% of Lebanese patients agree that herbal supplements got a disease curative effect, 38.32% of Lebanese patients agree that herbal supplements or herbal plants do not provide treatment, but can only be supportive and treatment is provided only with conventional medicines.

Moreover, 29.34% agree that herbal supplements or herbal plants have no side effects, 38.72% of Lebanese patients agree that herbal supplements or herbal plants do not interact with drugs and can be used at the same time. 38.12% of Lebanese patients agree that the use of herbal supplements or herbal plants can be dangerous, as they will affect the action of existing drug therapy. 37.12% of Lebanese patients agree that herbal supplements or herbal plants can be used as a last option to treat diseases, 33.53% of Lebanese patients agree that it is worth trying herbal supplements or herbal plants before visiting the physician, 37.32% agree that herbal supplements or herbal plants should not be used in the treatment of serious diseases, 41.71% of Lebanese patients agree that herbal supplements can be taken as a desire to boost energy and endurance. 31.73% agree that herbal supplements can help increase sports performance without being detected in blood tests, 42.51% of Lebanese patients agree that they should ask any pharmacist or physician about any herbal supplement or herbal plant before using it alone or with conventional treatment. 41.12% of Lebanese agree that they should investigate the ingredients and dosage of herbal supplements on the internet before taking them, and 44.11% of Lebanese patients agree that they should purchase their herbal supplements from a source, like a certified sports coach or a pharmacy. 44.51% of Lebanese patients agree that they would like to receive consultancy on herbal supplements or herbal plants to know more about how they act and interact in their bodies. 35.52% of Lebanese patients neither agree nor disagree that they would purchase herbal supplements from an online source or herbalist.

These results show that 56.7% of Lebanese patients consider that the pharmacist should provide complete information about herbal plant or herbal supplement and its usage with conventional medication While 20.8% of Lebanese patients consider the herbalist as the provider source of information about herbal plant or herbal supplement and its usage with conventional medication, 17% consider the physician and 0.4% consider the nurse, while 4.6% consider others, as illustrated by Fig. (3).

Fig. (3).

Source of herbal medicine recommendation.

Fig. (4).

Types of herbal products used by Lebanese out patients.

4. DISCUSSION

The results of this study have shown that 46.7% of participants consume herbal products and herbal supplements. In this study, we noticed that approximately half of the participants are more aware of the risks and the benefits of herbal supplements, and they can be an efficient part of the healthcare strategies to prevent HIDs in the Lebanese population.

29.1% of Lebanese patients didn’t ask a healthcare provider about herbal product usage and side effects [25, 26] as manyparticipants in this study were younger ageing between 25 and 30 years. Patients at high risk for HDIs who also take drugs with low therapeutic efficiency should be monitored more closely for herb-drug interactions, especially when a new drug is added or discontinued [27].

The overall prevalence of HDIs among Lebanese patients can occur due to the use of herbal products either in food, such as thyme-anticoagulants or antiplatelet drugs, which slows blood clotting and causes a risk of bruising and bleeding [28], Garlic-Anticoagulant/ Antiplatelet (warfarin/ aspirin) developed platelet disorders and/or hemorrhage [29] Figs. (1 and 3). So, patients using warfarin should be extremely cautious regarding the possible risk of increased bleeding with ingestion of garlic. Garlic-analgesics (paracetamol) causes changes in paracetamol pharmacokinetics [30]. Cinnamon-antihypertensives interaction which potentiates the effect of antihypertensive drug and causes hypotension [31], Cinnamon-analgesics/dyslipidaemia drugs can increase the risk of liver damage [32], Cinnamon-antidiabetics can cause hypoglycaemia [33], Apple cider vinegar can cause Antihypertensive (Furosemide) which increases the effect of Furosemide causing a decrease in potassium levels [34]. Curcumin/turmeric-anticoagulant (Fluindione) increases the risk of bleeding [35], and Romarin/rosemary-antihypertensives (Hydrochlorothiazide/ furosemide) increases hydrochlorothiazide and furosemide clearance [36]. The use of immunity/energy boosters with various medications can present various HDIs such as Ginkgo biloba - PPIs (Omeprazole), which decrease omeprazole blood concentration [37], Ginkgo biloba - Ibuprofen causes death due to cerebral haemorrhage (Inhibition of platelet aggregation) [38], and Ginkgo biloba - anticoagulant (warfarin) increases warfarin levels [39]. Ginseng-Anticoagulant (warfarin) increases anticoagulant effect [40], Ginseng- Insulin which has a synergistic action, increases insulin effects [41]. Ginseng- anxiolytic (Midazolam) reduces the effect of midazolam [37], Garcinia Cambogia -Antidiabetics causes hypoglycaemia [42], and Garcinia Cambogia- anticoagulants/antiplatelet drugs slows blood clotting that increases the risk of bruising and bleeding [43].

Oral herbal products, which are mainly used due to their sedative and relaxant effects may also interact extensively. Such oral herbal products are Valeriana root- Alprazolam/Benzodiazepines/Narcotics which increase sedative effects of Alprazolam [44], Ashwagandha-Benzodiazepines/Anticonvulsants/Barbiturates which increase sedative effects of benzodiazepines and narcotics [45], and Ashwagandha-Warfarin, clopidogrel which increases the risk of bleeding [16, 28]. Other herbal drinks such as Caffeine/Green tea may reduce Folic acid absorption and plasma levels [46]. Green tea may increase the risk of bleeding in patients taking warfarin [47]. Moreover, green tea/EGCG interacts with boronic acid-based agents such as the anticancer drug bortezomib, an approved proteasome inhibitor, where the therapeutic effect of bortezomib and other boronic acid-based proteasome inhibitors involve inhibiting the transport of irinotecan and its metabolite SN-38 during biliary elimination, leading to prolonged half-life and a potential increase in toxicity. Additionally, these inhibitors reduce the absorption of OATP drugs/substrates (such as etoposide and irinotecan) and enhance the bioavailability of tamoxifen [48].

Ginger root- antihypertensives (Nifedipine), which potentiates antiplatelet effects of nifedipine [49], Sage- anticoagulant/antiplatelet (Warfarin/ Clopidogrel), which increases anticoagulant effect of warfarin and reduces plasma levels of clopidogrel [50].

There are studies investigating the awareness and knowledge of herbal products by patients and pharmacists in various medical branches and health records [51, 52]. However, there is no study in Lebanon evaluating the use of herbal products by Lebanese patients in terms of the examination of Pharmacokinetics and Pharmacodynamics of HDIs. In addition, this study will contribute to the development of effective strategies for patient education and healthcare professionals to enable healthcare providers to deliver better guidance and advice regarding HDIs for their patients. This can positively affect the treatment process of the patients, as well as lead to lower dangerous consequences in terms of drug interactions and side effects. Considering herbal products as completely safe and self-management without health care provider guidance may cause negative consequences as some plants may have toxic components, and many herbal products also interact with drugs.

The most commonly known Herb-drug interaction by Lebanese participants is garlic or green tea with warfarin, in which both can alter blood haemostasis and anticoagulation of warfarin. This interaction can be obviously observed with Lebanese patients since 33.33% of Lebanese patients consume caffeine/ green tea and 33.93% consume garlic as herbal product in food, and 16.76% use anticoagulant or platelet as a conventional treatment. For this reason, it is necessary to raise awareness among Lebanese patients and pharmacists in order to provide the best treatment conditions and to prevent possible damages. It is extremely important for healthcare professionals to have comprehensive training in phytotherapy and to have sufficient knowledge and skills to enhance treatment effectiveness and prevent unwanted adverse effects. One of the most important issues regarding the use of herbal products is the information source through which the patients can obtain their knowledge about these products. In general, it is observed that 29.1% of Lebanese patients do not consult their doctors about this issue. In our study, 41.12% of the patients stated that they did research before using herbal products. So, by this step, they consider that the internet and social media are fast and reliable resources of information.

In this study, 28.14% of the Lebanese patients stated that herbal supplements or herbal plants do not interact with drugs and can be used at the same time, but 11.57% of the remaining patients disagreed with this view and 38.72% of them remained undecided. These results actually suggest that patients do not have enough information about toxic plants or their inappropriate use. Similarly, in the present study, 32.93% of the participants agreed with the aspect that the use of herbal supplements or herbal plants should be limited only to patients who have failed conventional therapy, while 12.17% of them disagreed and 33.93% of them were ignorant. These results suggest that some patients consider herbal products quite safe and ignore the possible side effects. However, the use of complementary therapies and herbal products in patients taking conventional medications for long term or chronic diseases should be used under medical supervision.

Regarding participants’ positive attitudes towards the knowledge of pharmacokinetics and pharmacodynamics of herbal products, most of them have shown a good knowledge of this issue (Table 3). The results of our study have shown that 39.32% of respondents are aware of the potential risks and side effects associated with herbal supplements or plants they use, 36.72% of Lebanese patients know the daily amount or dose of herbal plant or herbal supplement should be taken for their condition, 40.51% of Lebanese patients are knowledgeable of the effects occurring with the use of other conventional medication, 41.91% of the study respondents have agreed that herbal supplements should be regulated and controlled by the Ministry of Public Health (MOPH) and regulatory bodies to ensure safety and efficacy. On the other hand, 38.12% of participants agree that herbal supplements or herbal plants do not provide treatment but can only be supportive and treatment is provided only with conventional medicines. Whereas, 38.12% agree that the use of herbal supplements or herbal plants can be dangerous, as they will affect the current drug medical treatments, 37.32% of participants agree that herbal supplements or herbal plants should not be used in the treatment of serious diseases.

Table 3.
Patients' attitudes and behaviors towards the use of herbal products.
General Attitudes and Behaviors towards Herbal Medications Strongly Agree n (%) Agree n (%) Neutral
n (%)
Disagree
n (%)
Strongly Disagree n (%)
Natural and herbal medicine have side effects 119 (23.75%) 193 (38.52%) 147 (29.34%) 31 (6.18%) 11 (2.19%)
Natural medicine is more effective than conventional therapy. 89 (17.76%) 170 (33.93%) 176 (35.12%) 46 (9.18%) 20 (3.99%)
Herbal medicines are beneficial in healthcare management. 117 (23.35%) 231 (46.10%) 133 (26.54%) 15 (2.99%) 5 (0.99%)
Herbal supplements should be used after sports and physical training 99 (19.76%) 204 (40.71%) 136 (27.14%) 42 (8.38%) 20 (3.99%)
Herbal supplements interact with conventional medications and vitamins 128 (25.54%) 187 (37.32%) 154 (30.73%) 20 (3.99%) 12 (2.39%)
There are potential long-term health effects of taking herbal supplements. 97 (19.36%) 188 (37.52%) 180 (35.92%) 23 (4.59%) 13 (2.59%)
Herbal medicine is given only if patient’s failed conventional therapy 78 (15.56%) 165 (32.93%) 170 (33.93%) 61 (12.17%) 27 (5.38%)
Herbal medicine is safer than conventional medicine. 100 (19.96%) 165 (32.93%) 176 (35.12%) 40 (7.98%) 20 (3.99%)
I know the side effects of herbal medicine and their potential risk 94 (18.76%) 197 (39.32%) 178 (35.52%) 21 (4.19%) 11 (2.19%)
I know the correct dose, administration of herbal products and supplements 85 (16.96%) 184 (36.72%) 179 (35.72%) 33 (6.58%) 20 (3.99%)
Herbal-conventional interactions always occur even with spacing 106 (21.15%) 203 (40.51%) 164 (32.73%) 16 ((3.19%) 12 (2.39%)
Herbal supplements are regulated by the government 157 (31.33%) 210 (41.91%) 112 (22.35%) 12 (2.39%) 10 (1.99%)
Pharmacist education about herbal medicine is necessary 172 (34.33%) 204 (40.71%) 107 (21.35%) 10 (1.99%) 8 (1.59%)
Herbal therapy is always beneficial with no adverse effects 100 (19.96%) 208 (41.51%) 166 (33.13%) 18 (3.59%) 9 (1.79%)
Herbal supplements got a disease curative effect. 87 (17.36%) 219 (43.71%) 162 (32.33%) 24 (4.79%) 9 (1.79%)
Herbal medicine has synergistic effect along with conventional therapy 97 (19.36%) 192 (38.32%) 164 (32.73%) 39 (7.78%) 9 (1.79%)
Herbal-conventional interaction may be fatal and life threatening 97 (19.36%) 191 (38.12%) 165 (32.93%) 30 (5.98%) 18 (3.59%)
I try herbal medicine before visiting the doctor 89 (17.76%) 168 (33.53%) 160 (31.93%) 58 (11.57%) 26 (5.18%)
Herbal medicine is not used in critical ill patients or series illness 96 (19.16%) 187 (37.32%) 159 (31.73%) 38 (7.58%) 21 (4.19%)
Herbal supplements may boost immunity, energy, and libido 92 (18.36%) 209 (41.71%) 171 (34.13%) 20 (3.99%) 9 (1.79%)
Herbal medicine has no plasma level detecting test 96 (19.61%) 159 (31.73%) 188 (37.52%) 37 (7.38%) 21 (4.19%)
I ask the pharmacist or the physician about herbal medicine profile 136 (27.14%) 213 (42.51%) 126 (25.14%) 19 (3.79%) 7 (1.39%)
I search for the benefits and the risk of herbal medicine by internet 105 (20.95%) 202 (41.12%) 152 (30.33%) 27 (5.38%) 15 (2.99%)
I purchase herbal supplements from an online source, pharmacy, sports coach, herbalist 76 (15.16%) 148 (29.54%) 178 (35.52%) 52 (10.37%) 47 (9.38%)

Lebanese patients are willing to be more educated about herbal products use since 40.71% of Lebanese patients agree that there is a need for education about the risks and benefits of herbal supplements, and 42.51% of Lebanese patients ask pharmacists or physicians about herbal supplements or herbal plant before buying, 41.12% of Lebanese patients research the ingredients and dosage of herbal supplements on the internet before taking them, 44.51% of Lebanese patients like to receive consultancy on herbal supplement or herbal plants.

Another study concerning the knowledge of athletes about herbal products shows that 17% of college female athletes have used herbal supplements such as” “Guarana”, “Ashwagandha”, “Caffeine”, “Purple Willow Bark”, “Cayenne”, “Pepper”, and “Ginger root”. These products were believed to increase mental vigilance, stimulate fat-burning metabolism, and improve muscle performance [53]. Other plants such as Tribulus terrestris, Ginkgo biloba, Rhodiola rosea, and Cordyceps sinensis have demonstrated benefits on muscle growth and strength in active men, while others have shown no effect on muscle performances. Whereas, in this study, 28.94% Lebanese patients and especially the athletes, use these herbal supplements, mostly the Ashwagandha (21.15%), ginger root (16.96%), caffeine/green tea (33.33%) as energy boosters in order to increase energy and endurance, and 28.34% for relaxation from muscle spasms after sport exercises and 41.71% agree that herbal supplements can be taken as a desire to boost energy and endurance. Also 31.73% agree that herbal supplements can help increase sports performance without being detected in blood tests. Moreover, Ashwagandha can cause false positive results in benzodiazepine, thyroxine, digoxin drug tests, which can trigger false positive results that may affect certain lab test results [54].

Moreover, in the literature, the authors discuss the pharmacists’ knowledge, their experience of patient - reporting adverse reactions and their awareness of these reactions could play a vital role in identifying and reporting these reactions [51, 55]. The results of our study have shown significant similarities with previous studies and literature. Community pharmacists were not aware of potential herb–drug interactions, and an even larger majority did not receive complaints from the patients about herbal medicines. Thus, we recommend strategies taken by the Lebanese Ministry of Public Health (MOPH), Lebanese Hospitals, and Lebanese Pharmaceutical Companies to prevent or minimize the incidence of HIDs in society by raising awareness of pharmacists which will positively affect patients’ knowledge and correct herbal medicine practice.

In contrast to the literature, 56.7% of Lebanese patients get their source of information about herbal plants or supplements and their usage with conventional medication, while only 20.7% of Lebanese patients refer to the herbalist. Moreover, in this study, 44.11% of patients’ first choice was to purchase herbal supplements from pharmacies or certified sports coaches. Meanwhile, a lower percentage were inclined to purchase from an online source or herbalist as a second and alternate choice. Take into consideration that previous studies have shown that the primary consultant for herbal medicine use is the pharmacist only [56]. This reflects the trust of Lebanese patients towards their pharmacists, so pharmacists need enhanced education on pharmacokinetic and pharmacodynamics mechanisms, drug metabolizing enzymes, and transporters playing significant roles in herb-drug mechanisms in order to provide objective and evidence-based information on the benefits and risks of herbal medicines which might affect the general knowledge and awareness of the targeted population for better patient care and benefit in the future. Patient education and healthcare professionals play a crucial role in raising awareness and providing guidance on herb-drug interactions. The study highlights the high prevalence of herbal product use in Lebanon, driven by factors such as the unaffordability of synthetic medications and the economic crisis. The research aims to assess Lebanese patients' awareness and perception of herb-drug interactions and the role of pharmacists in providing consultation and information on herbal medicine use.

CONCLUSION

The study provides valuable insights into the awareness of herbal-drug interactions and the need for understanding these interactions among professionals and patients. Where various factors negatively affect the unauthorized use of herbal products, such as the economic crisis in Lebanon, which negatively affected the purchasing power of Lebanese patients to buy their conventional medications, the affordable prices of herbal medications, and the reputation of folk medicine practiced by ancestors. This study addresses athlete’s mindsets about herbal product use as well as shed light on developing effective strategies taken by the Lebanese Ministry of Public Health (MOPH), Lebanese Hospitals, and Lebanese Pharmaceutical Companies to prevent or minimize the incidence of HIDs among Athletes and Lebanese Population. Therefore, it is important to give credit to patient education and healthcare professionals in order to enable healthcare providers to deliver better awareness, guidance and advice regarding HDIs for their patients. Finally, more comprehensive studies should be conducted examining the benefit and harm profiles of herbal products among the Lebanese population.

AUTHORS’ CONTRIBUTION

M.A., R.B.: Study conception and design; R.Al-M.: Data collection: R.Al-M., M.A.: Analysis and interpretation of results; S.N., J.A.: Draft manuscript:

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

The study protocol was approved by the Institutional Review Board of the Lebanese International University, Lebanon (2023RC-006-LIUSOP).

HUMAN AND ANIMAL RIGHTS

All human research procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national), and with the Helsinki Declaration of 1975, as revised in 2013.

CONSENT FOR PUBLICATION

Informed consent was obtained from the participants.

STANDARDS OF REPORTING

STROBE and SAGER guidelines were followed.

AVAILABILITY OF DATA AND MATERIALS

The collection and processing of the data in this study complied with data protection and privacy. This cross-sectional descriptive study was performed from March until May 2023 from participants who accepted to fill the questionnaire and were interviewed during their visit to a community pharmacy.

FUNDING

None.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

We would like to thank all the Lebanese pharmacists in community pharmacies for their help in passing the surveys and data entry. We would also like to thank all the doctors in the School of Pharmacy at Lebanese International University for their vital assistance throughout this study.

REFERENCES

1
Firenzuoli F, Gori L. Herbal medicine today: Clinical and research issues. Evid Based Complement Alternat Med 2007; 4(Suppl 1): 37-40.
2
Azaizeh H, Saad B, Khalil K, Said O. The state of the art of traditional arab herbal medicine in the eastern region of the mediterranean: A review. Evid Based Complement Alternat Med 2006; 3(2): 229-35.
3
Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: A systematic review and update. Int J Clin Pract 2012; 66(10): 924-39.
4
Hunt KJ, Coelho HF, Wider B, et al. Complementary and alternative medicine use in England: Results from a national survey. Int J Clin Pract 2010; 64(11): 1496-502.
5
Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177.http://journal.frontiersin.org/article/10.33 89/fphar.2013.00177/abstract
6
WHO global report on traditional and complementary medicine 2019. 2019. Available from: https://iris.who.int/handle/10665/312 342
7
Abdelmola AO, Bahri A, Abuallut I, et al. Prevalence, knowledge, and perception about the use of herbal medicines jazan - Saudi Arabia. J Family Med Prim Care 2021; 10(6): 2386-93.
8
El-Dahiyat F, Rashrash M, Abuhamdah S, Abu Farha R, Babar ZUD. Herbal medicines: A cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults. J Pharm Policy Pract 2020; 13(1): 2.
9
AlBedah AMN, Khalil MKM, Elolemy AT, et al. The use of and out-of-pocket spending on complementary and alternative medicine in Qassim province, Saudi Arabia. Ann Saudi Med 2013; 33(3): 282-9.
10
Awad A, Al-Shaye D. Public awareness, patterns of use and attitudes toward natural health products in Kuwait: A cross-sectional survey. BMC Complement Altern Med 2014; 14(1): 105.
11
Déciga-Campos M, Ventura-Martínez R, González-Trujano ME, Silveira D. Editorial: Pharmacological interaction between drugs and medicinal plants. Front Pharmacol 2022; 13: 1081090.
12
Salm S, Rutz J, van den Akker M, Blaheta RA, Bachmeier BE. Current state of research on the clinical benefits of herbal medicines for non-life-threatening ailments. Front Pharmacol 2023; 14: 1234701.
13
El-Shemy H. Aromatic and Medicinal Plants: Back to Nature 2017.
14
Naja F, Alameddine M, Itani L, Shoaib H, Hariri D, Talhouk S. The use of complementary and alternative medicine among lebanese adults: Results from a national survey. Evid Based Complement Alternat Med 2015; 2015: 1-9.
15
Zhou S, Zhou Z, Li C, et al. Identification of drugs that interact with herbs in drug development. Drug Discov Today 2007; 12(15-16): 664-73.
16
Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355(9198): 134-8.
17
Choudhury A, Singh PA, Bajwa N, Dash S, Bisht P. Pharmacovigilance of herbal medicines: Concerns and future prospects. J Ethnopharmacol 2023; 309: 116383.
18
Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003; 52(9): 1361-71.
19
Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010; 55(6): 515-25.
20
Roberts H. Safety of herbal medicinal products in women with breast cancer. Maturitas 2010; 66(4): 363-9.
21
Asif M. A brief study of toxic effects of some medicinal herbs on kidney. Adv Biomed Res 2012; 1(1): 44.
22
Rhee TG, Ng JY, Dusek JA. Utilization and perceived benefits of homeopathy and herbal therapies in U.S. adults: Implications of patient-centered care. Complement Ther Clin Pract 2017; 29: 9-15.
23
Lebanon demographics profile. 2021. Available from: https://www.indexmundi.com/lebanon/demographics_profile.html
24
Epi Info 2000: A database, and statistics program for public health professionals for use on Windows 95, 98, and NT computers. 2000. Available from: https://stacks.cdc.gov/view/cdc /23207
25
Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: The D-PRESCRIBE randomized clinical trial. JAMA 2018; 320(18): 1889-98.
26
Desborough JA, Clark A, Houghton J, et al. Clinical and cost effectiveness of a multi-professional medication reviews in care homes (CAREMED). Int J Pharm Pract 2020; 28(6): 626-34.
27
Shrank WH, Avorn J. Educating patients about their medications: The potential and limitations of written drug information. Health Aff (Millwood) 2007; 26(3): 731-40.
28
Hazra S, Singh PA, Bajwa N. Safety issues of herb-warfarin interactions. Curr Drug Metab 2024; 25(1): 13-27.
29
Verma T, Aggarwal A, Dey P, et al. Medicinal and therapeutic properties of garlic, garlic essential oil, and garlic-based snack food: An updated review. Front Nutr 2023; 10: 1120377.
30
Kansara MB, Jani AJ. Possible interactions between garlic and conventional drugs: A review. Pharm Biol Eval 2017; 4(2): 73.
31
Mousavi SM, Karimi E, Hajishafiee M, Milajerdi A, Amini MR, Esmaillzadeh A. Anti-hypertensive effects of cinnamon supplementation in adults: A systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2020; 60(18): 3144-54.
32
Khiabani Rad M, Vazifeh Shiran N, Mohammadi MH, Hamidpour M. Evaluating the effect of cinnamon and rosuvastatin, on the formation of foam cells in macrophages co-cultured with platelets. Adv Tradit Med 2022; 22(2): 271-81. (ADTM).
33
Vijayakumar K, Prasanna B, Rengarajan RL, Rathinam A, Velayuthaprabhu S, Vijaya Anand A. Anti-diabetic and hypolipidemic effects of Cinnamon cassia bark extracts: An in vitro, in vivo, and in silico approach. Arch Physiol Biochem 2023; 129(2): 338-48.
34
Sleeper RB, Kennedy SM. Adverse reaction to a dietary supplement in an elderly patient. Ann Pharmacother 2003; 37(1): 83-6.
35
Bahramsoltani R, Rahimi R, Farzaei MH. Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. J Ethnopharmacol 2017; 209: 1-12.
36
Kang YJ, Lee CH, Park S-J. Involvement of organic anion transporters in the pharmacokinetics and drug interaction of rosmarinic acid. Pharmaceutics 2021; 13(1): 83.
37
Unger M. Pharmacokinetic drug interactions involving Ginkgo biloba. Drug Metab Rev 2013; 45(3): 353-85.
38
Maria JA, Luis MB, Paulina B. An update on drug interactions with the herbal medicine Ginkgo biloba. ; 11(2): 171-81.
39
Vaes LPJ, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: Nature of the evidence. Ann Pharmacother 2000; 34(12): 1478-82.
40
Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000; 57(13): 1221-7.
41
Lee KJ, Lee SY, Ji GE. Diabetes-ameliorating effects of fermented red ginseng and causal effects on hormonal interactions: Testing the hypothesis by multiple group path analysis. J Med Food 2013; 16(5): 383-95.
42
Chen TH, Fu YS, Chen SP, Fuh YM, Chang C, Weng CF. Garcinia linii extracts exert the mediation of anti-diabetic molecular targets on anti-hyperglycemia. Biomed Pharmacother 2021; 134: 111151.
43
Sharma A, Joseph GS, Singh RP. Antioxidant and antiplatlet aggregation properties of bark extracts of Garcinia pedunculata and Garcinia cowa. J Food Sci Technol 2014; 51(8): 1626-31.
44
Carrasco MC, Vallejo JR, Pardo-de-Santayana M. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother Res 2009; 13(12): 1795-6.
45
Kumar M, Patel M, Chauhan R, et al. Elucidation of genotype–environment interactions and genetic stability parameters for yield, quality and agromorphological traits in ashwagandha (Withania somnifera (L.) Dunal). J Genet 2020; 99(1): 59.
46
Alemdaroglu NC, Dietz U, Wolffram S, Spahn-Langguth H, Langguth P. Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: Potential risk of diminished folic acid bioavailability. Biopharm Drug Dispos 2008; 29(6): 335-48.
47
Werba JP, Misaka S, Giroli MG, et al. Update of green tea interactions with cardiovascular drugs and putative mechanisms. Yao Wu Shi Pin Fen Xi 2018; 26(Suppl 2): S72-7.
48
Ben-Arye E, Samuels N, Goldstein LH. Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals. Cancer 2016; 122(4): 598-610.
49
Dasgupta A, Hammett-Stabler CA. Herbal Supplements 2010.
50
Leite PM, Martins MAP, Castilho RO. Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy. Biomed Pharmacother 2016; 83: 14-21.
51
Chang ZG, Kennedy DT, Holdford DA, Small RE. Pharmacists’ knowledge and attitudes toward herbal medicine. Ann Pharmacother 2000; 34(6): 710-5.
52
Santanello C, Carr A. Pharmacists’ knowledge, perceptions, and practices regarding herbal medicine. Innov Pharm 2019; 10(3): 15.
53
Garcia JF, Arribalzaga S, Díez R, et al. Herbs as an active ingredient in sport: Availability and information on the internet. Nutrients 2022; 14(13): 2764.
54
Dasgupta A, Johnson MJ, Wahed A. The New LOCI digoxin assay on the vista 1500 analyzer is virtually free from interferences of herbal supplements hawthorn and ashwagandha (Indian ginseng). J Clin Lab Anal 2012; 26(4): 227-31.
55
Iqbal MS, Tahir M, Upadhyay DK, Iqbal MZ, Rajan S, Albassam A. Knowledge of the use of herbal medicines among community pharmacists and reporting their adverse drug reactions. J Pharm Bioallied Sci 2020; 12(4): 436-43.
56
Al-Arifi MN. Availability and needs of herbal medicinal information resources at community pharmacy, Riyadh region, Saudi Arabia. Saudi Pharm J 2013; 21(4): 351-60.